key: cord-0960765-0b2kds9k authors: Seifi, Tahereh; Reza Kamali, Ali title: Antiviral performance of graphene-based materials with emphasis on COVID-19: A review date: 2021-05-25 journal: Med Drug Discov DOI: 10.1016/j.medidd.2021.100099 sha: 1c4cb07992e28730881e8a258b95edb581451cb9 doc_id: 960765 cord_uid: 0b2kds9k Coronavirus disease-2019 has been one of the most challenging global epidemics of modern times with a large number of casualties combined with economic hardships across the world. Considering that there is still no definitive cure for the recent viral crisis, this article provides a review of nanomaterials with antiviral activity, with an emphasis on graphene and its derivatives, including graphene oxide, reduced graphene oxide and graphene quantum dots. The possible interactions between surfaces of such nanostructured materials with coronaviruses are discussed. The antiviral mechanisms of graphene materials can be related to events such as the inactivation of virus and/or the host cell receptor, electrostatic trapping and physico-chemical destruction of viral species. These effects can be enhanced by functionalization and/or decoration of carbons with species that enhances graphene-virus interactions. The low-cost and large-scale preparation of graphene materials with enhanced antiviral performances is an interesting research-direction to be explored. During the last two decades, coronaviruses (CoVs) have been the cause of local and global epidemics, including Severe Acute Respiratory Syndrome (SARS) [1] [2] [3] [4] [5] [6] , Middle East Respiratory Syndrome (MERS) [7] [8] [9] [10] , and Porcine epidemic diarrhea virus (PEDV) with the mortality rate around 10%, 35% and 95% respectively, threatening human health and economic well-being. For instance, the latter caused ten percent reduction of pig population in USA 2013 [11, 12] . Currently, the pandemic outbreak of the febrile respiratory disease, so called COVID-19 [13, 14] has created a global transmission network, leading to an international crisis related to the catastrophic losses of human lives and financial meltdowns. As such, the exploration of effective antiviral agents that can be effective on COVID-19 is of great importance. Given this, the current article concerns the potential capability of graphene-based materials for antiviral therapy applications. To this end, first a brief review on the basic aspects associated with coronaviruses is made, based on which the influences of drugs are discussed. Coronaviruses are categorized as pleomorphic enveloped viruses with single-strand positive sense RNA genome ranging 26-32 kb in size [15] [16] [17] [18] . The genome of CoVs is packaged into a helical capsid surrounded by a virion envelope, containing at least three proteins including the spike, membrane and envelope-types proteins. The schematic representation of coronavirus virion structure, and spike proteins are illustrated in Fig. 1 [19, 20] . 3 Fig. 1 . The schematic illustration of (a) the typical coronavirus virion structure, highlighting the presence of three types of proteins marked as "P." generated based on information extracted from [19] . (b) Coronavirus spike protein; subunit S1: the receptor-binding, subunit S2: the membrane-fusion; TM: the transmembrane anchor; IC: the intracellular tail and the viral envelope generated based on information extracted from [20] . Furthermore, other types of proteins such as hemagglutinin esterase may also exist on CoVs. It should be mentioned that membrane and envelop proteins are considered as transmembrane proteins that are important in the virus assembly. In contrast, the spike proteins play an essential role to infect the host cells [19] [20] [21] . The structure of spike proteins available on the surface of virion is shown in Fig. 1b , in which the crown shaped protein is formed of two domains, namely an amino (N)-terminal domain (subunit S1), and a carboxy (C)-terminal domain (subunit S2). Subunit S1 is responsible for binding of the virus to the host cell receptors, while subunit S2 causes the membrane fusion that allows entering viral genomes into the host cell [19, 22, 23] . Therefore, COVID-19 can infect human cells through binding of its S proteins to human ACE2 The effective fight against viruses requires the detailed knowledge of ways through which the virus can invade host cells. This involves three main steps of (a) the cellular attachment and entry, (b) the replication of viral genome and viral proteins expression, and (c) the assembly, maturation, and exocytosis. Therefore, viruses rely on their host cell proteins and processes based on the above mentioned mechanisms [93] . Fig. 2 illustrates the essential steps involved in the virus replication cycle [94] . This can also highlight possible ways to combat against viruses, based on which, an effective antiviral material should inhibit at least one of the virus replication cycles. As presented in the right side of Fig. 2 , an antiviral target may attack a virus at any stage of its replication cycle. Not to mention that targeting the early steps of the virus entry is considered as 7 an appropriate strategy for therapeutic intervention. It is because the inhibitor can attack the virus extracellularly, providing a larger accessibility to the virus, and less damage to the host cell [94] . For the case of COVID-19, like any other new infectious disease without definitive and/or effective treatments, two major strategies are considered to counteract the infection, based on drug repurposing and the discovery of novel drugs. Drug repurposing can be a feasible strategy for combating epidemic diseases, since it considerably shortens the time of drug development, supporting a swift response to the spread of the novel virus species. As an example of the drug repurposing for COVID-19, one can indicate metal-based drugs which have been suggested as promising candidates to control the coronavirus [95] . Metallodrugs such as the gold drug auranofin (2,3,4,6-tetra-o-acetyl-L-thio-β-D-glycol-pyranoses-S-(triethyl-phosphine)-gold(I)) has shown antiviral influences against COVID-19 in vitro [96] . However, the general problems associated with the use of metal compounds is valid here as well, including the systemic toxicity [97] . Based on molecular mechanics-assisted structure-based virtual screening method, Teralı et al. [98] reported a list of drug repurposing candidates which can be used as inhibitors of COVID-19. These drugs include lividomycin, quisinostat, spirofylline, burixafor, pemetrexed, edotecarin, diniprofylline and fluprofylline [98] . Subsequently, the virus or its genome enters in the cytoplasm of the cell, followed by the liberation of the genome from its the protective capsid, it is then transcribed and viral mRNA directs the host cell to synthesize viral enzymes and capsid proteins, and to assemble new virions, which are then released from the cell. The virus can be targeted by antiviral drugs at each step of the cycle mentioned above, as shown in the right side of the image [94] . Furthermore, some medicines such as chloroquine, hydroxychloroquine, remdesivir, tocilizumab and lopinavir/ritonavir have shown controlling effects on COVID-19 patients [99] [100] [101] [102] [103] [104] . In addition to these, zinc supplements exhibit inhibitory effects on the replication of COVID-19 in infected cells, when used with chloroquine [105] . While this strategy of treating COVID-19 is promising, further examinations should be conducted in order to evaluate the performances and side effects of such drugs which may appear in the presence of the new virus species. Computational simulations can provide valuable information that is difficult or expensive to be obtained experimentally. Speciale et al. [106] conducted a fundamental study based on the computational analysis, and reported on the potential of silibinin to prevent COVID-19 entry into cells due to the formation of a stable complex between COVID-19 spike protein receptor binding domain (RBD) and silibinin. Moreover, silibinin was found to be effective for inhibiting COVID-19 replication due to interactions with aminoacidic residues on the active site of COVID-19 main protease [106] . Another study based on the molecular docking showed that doxepin could inhibit viral entry into the host cells due to binding to ACE2. In this case, doxepin exhibits hydrophobic interactions, and supports hydrogen bonding with COVID-19 spike protein RBD [107] . Another molecular simulation-based research demonstrated the inhibitory ability of glucocorticoids (betamethasone, dexamethasone, hydrocortisone, fludrocortisone, ciclesonide and triamcinolone) against COVID-19 via binding interactions between the selected glucocorticoids and COVID-19 main protease pocket amino acids [108] . A combination of such computational analyses using the available drugs with sufficient experimental trials is required for the successful delivery of efficient drugs for new viruses. 10 The second strategy in combating COVID-19, which is based on discovering novel drugs, is more complicated and time consuming. It is because the process of new drug discovery requires more fundamental theoretical studies, the production of new drugs and various evaluations to confirm the efficiency of the developed drugs in vitro, then in vivo. Furthermore, additional experiments are needed to ensure the biocompatibility as well as environmental safety of such drugs, leading to the requirement for additional funding and time. Despite these limitations, the second strategy of combating new viral infections has the higher potential of providing drugs with unique advantageous properties, than those currently available. In this regard, strengthening the immune system can be an important factor in reducing the mortality of viral diseases, which may be combined with herbal drugs. The latter can be produced from various parts of plants such as seeds, barks, flowers, roots, stems, and fruits for immunomodulating and strengthening the immune system [109, 110] . Moreover, the alkaloids, flavonoids and polyphenol exist in some plants such as garlic, peppermint, oregano, ginger, licorice, tulsi, turmeric, echinacea, astragalus, and fennel can cause the release of antibodies and interferons toward viral infections [109] . For instance, Echinaforce ® , a herbal medicine derived from Echinacea purpurea, has been shown to be effective in inactivation of HCoV-229E, MERS-CoV, SARS and COVID-19 at least in vitro [111] . Also, based on the molecular docking technique, Thuy et al. [112] reported the inhibitory effect of garlic essential oil toward COVID-19 due to the strong interactions between the 17 organosulfur compounds of the garlic essential oil and the amino acids of the ACE2 protein as well as the main protease PDB6LU7 of COVID-19. Furthermore, organometallic compounds such as sodium copper chlorophyllin synthesized from chlorophyll show antibacterial and antiviral activity [113, 114] . An enhanced level of antiviral activities can be achieved using nanomaterials, as discussed in the next section. Nanotechnology has been playing a vital role in the recent progress of biomedicine and bioengineering, including the synthesis and application of therapeutic nanomaterials for various applications such as cancer diagnosis and therapy, drug delivery and tissue engineering [115] [116] [117] . In general, two approaches can be distinguished in the application of nanomaterials against viruses. One approach considers an external stimulus which can kill viruses [130] . The other approach is related to the interaction between the surfaces of the viruses and the nanomaterial employed as the antiviral agent. The first approach may be implemented by the application of light or Near Infrared (NIR) irradiation. For example, Akhavan et al. [131] reported on the photoinactivation performance of thin films of graphene−tungsten oxide nanocomposites against bacteriophage MS2 viruses under visible light irradiation. In this case, the protein capsid photodegradation and effluxion of the RNA are identified as the mechanisms of bacteriophage MS2 virus inactivation [131] . The second approach highlights the antiviral performances of nanostructured materials. It was reported that human coronaviruses can survive on non-living surfaces, including glass-, plasticor metal-surfaces for nine days [132] . Therefore, using surfaces with the ability to kill pathogens would be highly beneficial to prevent the spread of infections. Perhaps one of the first reports on the impact of nanostructured topography toward COVID-19 was presented by Hasan et al. [133] who demonstrated the antiviral performance of the surfaces of nanostructured aluminium 6063 alloy against COVID-19. The alloy was synthesized by the wet etching technique. The use of such nanostructure surfaces can be an interesting approach toward the reduction of environmental contaminations and hospital infections, and consequently, the transmission of COVID-19. Copper alloy surfaces are also reported to possess anti-pathogenic performance, reducing the infectious disease transmission from fomites [132, [134] [135] [136] [137] . The surfaces of copper alloy, therefore, may limit the spread of COVID-19 [138] . As for comparison, COVID-19 could survive for three days on plastic and stainless steel surfaces, but no live COVID-19 could be detected on copper alloy surfaces only after four hours of exposure [139] . In fact, copper has been shown to have antiviral ability against both enveloped and nonenveloped various genomes (single or double strand DNA and RNA) such as human immunodeficiency virus type 1 (HIV-1), bronchitis virus and poliovirus [140, 141] . As another example of metallic materials with antiviral performance, one can name silver nanoparticles. Immunofluorescence studies confirmed that the polyvinylpyrrolidone polymer coated with 10 nm silver nanoparticles could inhibit COVID-19 infection towards VeroE6/TMPRSS2 cells. Here, the effect of nanostructuring was highlighted, since the application of silver particles with sizes around 100 nm could not provide an appropriate antiviral performance [142] . Apart from alloys and coatings, the antiviral performances of nanoparticles in powder forms have also been of interest. For instance, silver nanoparticles with the sizes of 2-15 nm exhibit antiviral activity against COVID-19 [142] . However, since metallic nanoparticles are highly reactive in powder forms, the application of metal oxide powders is of importance. As a good 13 example in this field, one can indicate the antiviral performance of tin oxide (SnO 2 ) nanowires against HSV-1 infection. In this case, SnO 2 nanowires work as a carrier of negatively charged structures that compete with HSV-1 attachment to cell bound heparan sulfate, and therefore, inhibit the entry and the subsequent cell-to-cell spread [143] . SnO 2 has also been used for the destruction of antiviral drugs, such as abacavir after the treatment of HIV [144] . The strategy of using metal oxide nanostructures is attractive, since such materials can be produced at low-cost using environmentally friendly approaches [145] [146] [147] . As another example of using metal oxides, Abo-zeid et al. [148] reported on the potential application of iron oxide nanoparticles to inactivate COVID-19. Their results obtained using molecular docking studies show that both Fe 2 O 3 and Fe 3 O 4 are able to interact with the spike protein of COVID-19 (subunit S1 in Fig. 1b ), but Fe 3 O 4 binding was found to be more stable. According to this study, under the influence of iron oxide nanoparticles, COVID-19 can lose its ability to attach to the host cell receptors [148] . It follows from what is mentioned above that the characteristics of surfaces of nanostructured materials can provide a critical influence on their antiviral performances. In fact, the application of non-toxic substances that can effectively combat COVID-19 and future viral outbreaks should be very important towards the control of virus infections. One of those non-toxic nanomaterials is graphene, as discussed in next sections. As an interesting member of carbon nanostructures, graphene, the building block of graphite, can be defined as an atomically two-dimensional layer of hexagonally bonded carbon atoms. Such carbon structure can exhibit outstanding properties such as large specific surface area, high 14 mechanical strength, high electron conductivity as well as strong thermal, optical and catalytic characteristics [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] . Graphene-based materials are referred to those materials that contain single or few-layer graphene or graphene oxide [161, 162] in their structures. Furthermore, high quality graphene materials may be produced at large scales using low cost methods that employ highly available resources such as graphite [163, 164] , biomass [165] and waste plastics [166, 167] , making them attractive for commercial applications. These unique properties of graphene and its derivatives have made these nanostructured materials suitable for various biological and medical applications [168] including anti-pathogenic applications [169] [170] [171] [172] [173] [174] [175] [176] [177] , biosensors [178] [179] [180] [181] [182] [183] [184] , bioimaging [185] [186] [187] [188] [189] [190] [191] [192] , tissue engineering [193] [194] [195] [196] , drug delivery [197] [198] [199] [200] [201] . Therefore, the interactions between graphene materials and viruses should be of great interest. It should be mentioned that the antibacterial activity of graphene nanomaterials can be explained based on various effects including membrane-, oxidative-, and/or photothermal-stresses as well as charge transfer, and the entrapment effect of graphene materials on various bacterial species, as recently reviewed somewhere else [255] . In comparison with bacteria, relatively very little is known about the antiviral performances of graphene materials, mainly because of significant differences in the size of virus (2-300 nm) and bacteria (500-5000 nm), which makes the viral studies more difficult and/or expensive to be conducted [256, 257] . This article reviews the antiviral activity of graphene nanomaterials, based on the available literature. 15 As briefly discussed above, graphene-based materials can be used in various biomedical fields, including the rapid and accurate detection of virus species, personal protective equipment such as masks, gowns and gloves, as well as the antiviral applications [202] [203] [204] [205] [206] [207] [208] [209] [210] . One important and common aspect of these studies is related to the interactions between the virus and graphenebased materials. Chowdhury et al. [211] reported on the electrochemical detection of Hepatitis E virus (HEV) by a graphene-based nanocomposite, defined as nitrogen-and sulfur-co-doped graphene quantum dots (QDs) and gold embedded polyaniline nanowire [211] . Here, gold nanoparticles loaded polyaniline nanowire enhances the electron transfer process and provides a large surface area on which the monoclonal antibody-conjugated graphene QDs can be loaded. The latter could provide active sites for the target HEV. Introducing an external electrical pulse during the virus accumulation step increases the sensitivity of the antiviral agent towards HEV compared to other conventional electrochemical sensors. It is because the external electrical pulse can cause the expansion of the surface of the virus as well as the length of the antibody-conjugated polyaniline chain [211] . This research may highlight the capability of graphene QDs (with sizes of around 500 nm) to be effectively attached to the virus species. This example highlights that interactivity of graphene with surrounding environment plays a key role in the overall performance of the material. It should be mentioned that graphene edge can be of particular interest due to the presence of dangling bonds, representing at least two times greater reactivity in comparison with the basal plane [212, 213] . In contrast with graphene, graphene oxide (GO) is the oxidized form of graphene with hydroxyls, epoxides, diols, ketones, or carboxyls functional groups located on its surface. The presence of oxygen on the edges and basal planes of GO increases its hydrophilicity, water dispersibility, and 16 attachability in comparison with graphene [214, 215] . Given this, Song et al. [216] further highlighted the capability of GO to capture EV71 (the agent of hand, foot and mouth disease) and H 9 N 2 (the agent of avian influenza A virus) at 56 °C. GO was able an efficiently destroy the coating proteins available on these viruses and extracting the viral RNA in an aqueous environment. This interaction leads to the superficial bioreduction of GO, leading to its conversion into graphene form, while killing the virus [216] . It should be mentioned that the graphene formed by the reduction of GO is often called reduced graphene oxide (rGO). The reduction of GO can also occur during thermal reduction treatments [217, 218] . Ziem et al. [219, 220] produced thermally rGO sheets functionalized by polysulfated dendritic polyglycerol. This functionalized rGO material showed antiviral performance against a range of viruses comprising orthopoxviruses, herpes simplex virus type 1 (HSV-1) and equine herpesvirus type 1 (EHV-1). These viruses cause the significant global health problems such as HSV-1 and orthopoxviruses that infect humans, and EHV-1 that infects horses. It was demonstrated that the binding of polar polymers to the carbon material leads to enhanced solubility in water. It also results in a bioinert multifunctional surface that is easily accessible for further post-modification and biological interactions. The subsequent sulfation of the material promotes the interaction of the material with viruses. Here, graphene scaffolds with the large surface area provide the opportunity to increase the valency of the dendritic polyglycerol sulfate groups [219, 220] . As shown in Fig. 1 , the binding and entering of viruses into the host cell, the virus must first interact with the host cell surface receptors. In viral envelope glycoproteins, heparan sulfate proteoglycans and chondroitin sulfate proteoglycans function as the cell surface receptors [221, 222] . Given this, functionalized graphene materials can prevent cellular viral infections based on the interaction between negatively charged functional groups which mimic cell surface heparan sulphate [219, 220] . In addition to this, the size of graphene flakes and the degree of sulfation could influence the antiviral activity of the functionalized graphene materials. Accordingly, the flake sizes of around 300 nm together with around 10% functionalization could provide the optimum performance [220] . Elechiguerra et al. [223] coated silver nanoparticles with carbon, bovine serum albumin and poly N-vinyl-2-pyrrolidone, and evaluated the antiviral performances of the resultant materials against HIV-1 virus. Out of these samples, carbon coated silver nanoparticles showed a higher level of antiviral performance [223] , which could be related to their surface chemistry, providing a higher reactivity against the virus. The feline coronavirus (FCoV), and the infectious bursal disease virus (IBDV) have been used to evaluate the antiviral performances of graphene materials. FCoV belongs to the genus alphacoronavirus with its positive-sense, single-stranded RNA and a lipid envelope (Fig. 3a) . Cats show feline infectious peritonitis because of this virus, and the spread of the virus is possible through the direct contact with infected secretions [224] . IBDV is a member of the family Birnaviridae and the genus Avibirnavirus. It is a non-enveloped virus with doublestranded RNA (Fig. 3b) [225, 226] . This virus is responsible for the infectious bursal disease, also called Gumboro disease in young chickens, inducing immunosuppression, leading to a significant economic losses [227, 228] . Chen et al. [229] evaluated the antiviral activity of GO and GO-Ag nanocomposites against FCoV and IBDV. The schematic structures of these viruses as well as the graphene-based antiviral species are shown in Fig. 3 . It was found that GO-Ag exhibit a higher level of antiviral activity than GO. Accordingly, the GO-Ag nanocomposite was capable of controlling FCoV and IBDV by 25% and 23%, respectively; whereas GO only showed 16% inhibition of FCoV and no inhibition against IBDV. Antiviral mechanism involved in the antiviral performance of GO and GO-Ag could be explained based on the structural features, highlighted in Fig. 3 Instead, GO contributes in the overall performance of the antiviral agent by providing a substrate for silver particles to be well dispersed without obvious aggregation [229] . Further investigations confirm the electrostatic interactions between GO/rGO species and oppositely charged lipid membranes, leading to the adsorption of graphene materials followed by the rupture of the liposome [230, 231] . Such an electrostatic force-driven interaction has also been described for the case of porcine epidemic diarrhea virus with positive-strand RNA genome from genus alphacoronavirus, and also the pseudorabies virus with double stranded DNA genome from genus alphaherpesvirus [232] . Here, the antiviral mechanism of GO against these viruses was discussed to be based on the interaction between negatively charged surfaces of GO with sharp edges, and positively charged viruses. It should also be noted that GO could only show an antiviral activity if used before the viral absorption, so that the application of GO simultaneously or after viral infection, had no effect on the infection [232] . 20 As another example, Sametband et al. [233] reported that the charge density is the most important factor influencing the antiviral properties of GO and rGO−SO 3 against HSV-1. Both graphene materials mentioned above could prevent the attachment of the viruses to host cell surface receptors, mimicking heparan sulfate biological activities. It should be added that the heparan sulfate, GO and rGO−SO 3 all have a negative charge [233] . As could be realized from the cases mentioned above, the surface physiochemical properties of GO, rGO and the structures based on these nanocarbons exhibit essential roles in their antiviral performance, influencing cells viability [234] . In this context, it was observed that the nanotopology of the graphene layers have a significant implication on the physical/mechanical properties of graphene augmented alumina nanofiber scaffolds, which in turn plays an important role in their antiviral performance against human pathogenic viruses (HPeV1 and IAV) through binding with viruses. Since the performances of graphene materials rely on surface-dependent reactions, their concentration and the exposure time period should also be important factors influencing their overall antiviral activity. A good example here is the work of Yang et al. [236] who investigated the concentration-dependent antiviral performance of the curcumin-loaded β- further shown that GSCC could block the receptors of Human laryngeal epithelial type 2 (HEp-2) cells, providing an inhibitory role against the infection [236] . Here, it is relevant to mention about the antiviral performance of carbon quantum dots (CQDs), which are categorized as mainly sp 2 graphitic structures with sizes of typically less than 10 nm [238, 239] . Due to their structural features, CQDs are capable of being functionalized with various functional groups to provide antiviral activities. For instance, CQDs functionalized with boric acid showed antiviral activity against HCoV-229E. Here, two mechanisms were found to be responsible for antiviral of activities: 1) the prevention of the infectious interactions between host cells and viruses, achieved by the attachment of CQDs (with an average diameter of around 7 nm) to the S-protein of viruses; and 2) the ability of CQDs to inhibit the RNA genomic replication. The presence of boronic acid functions proved to be vital for revealing the antiviral activity [240] . Similar results were obtained by Barras et al. [241] who reported on the ability of 4-aminophenylboronic acid hydrochloride functionalized carbon nanodots to prevent HSV-1 infection. Fig. 4 highlights the antiviral activity of CQDs. Regenerated from [244] . Copyright 2017, with permission from ACS Publications. The state-of-the-art knowledge about the antiviral performances of graphene based materials, summarized above indicate several mechanisms by which graphene materials can potentially combat coronaviruses, perhaps, including COVID-19. Despite the valuable knowledge available, there are still various ambiguities and controversies involved in the antiviral application of graphene materials, including the virus mutation, the interactions between graphene and various human genetics, side effects, and the associated cytotoxicity [246] [247] [248] [249] [250] [251] . These issues should be considered in future studies. The virus outbreaks that threaten the health of people worldwide provide the motivation to search for efficient the antiviral agents. Given this, the current article concerned the antiviral 25 performances of selected nanomaterials, with an emphasised on the antiviral performances of graphene-based materials. In terms of drug development, there are two strategies for combating coronaviruses including COVID-19, comprising drug repurposing and the discovery of novel drugs. Following the second strategy, Table. 1, provides a summary of the performances of some antiviral agents, to inactivate coronaviruses, comprising iron oxide and silver nanoparticles, as well as nanostructured aluminum 6063, and copper alloys. While appropriate antiviral performances can be achieved using these materials, other parameters such as the safety, toxicity, and cost of antiviral agents can play an important role in the possibility of their large scale application. Among the novel antiviral materials highlighted in Table 1 , graphene-based materials may provide advantages of large availability, non-toxicity and low-cost. based on their capability to be functionalised, and also be used as the substrate to homogeneously load other antiviral agents. Given this, those characteristics of graphene materials influencing their antiviral performances include the surface area, charge density and the concentration of graphene materials, as well as the type and size of loaded particles, the type and degree of 26 functional groups. On the other hand the virus characteristics such as enveloped or nonenveloped viruses and the time of usage the nanomaterials (virus pre-treatment, virus cotreatment, cell pre-and post-treatment) also essential roles in the determining the antiviral activity of graphene-based materials. Finally, it should be emphasised that carbon materials can provide multi-functional performances which can be employed for the decomposition of organic pollutants [252, 253] , adsorption of heavy metals [254] and killing of infectious pathogens, increasing the efficiency of carbons towards environmental protections. The development of efficient carbon-based materials can support the global efforts towards combat bacterial [255] and viral infections. Reduction from 5 × 10 7 to 2.5 × 10 5 pfu/mL [232] Cationic CQDs (125 μg/mL) PEDV (+) RNA Inhibition the virus entry over 50% [258] Graphene quantum dots HIV (+) RNA IC 50 Copper-graphene nanocomposite (5 μM) Influenza A RNA ∼50% reduction [264] * Antiviral activity % = (log 10 (TCID 50 /mL of virus) -log 10 (TCID 50 /mL of treatment)) / log 10 (TCID 50 /mL of virus) × 100% ** IC 50 is the half maximal inhibitory concentration in vitro for inhibition the activity of RNA-dependent DNA polymerase. EC 50 is the half maximal effective concentration for reduction 50% the HIV-1-induced cytopathic effect in MT-4 cells. Characterization of A novel coronavirus associated with severe acute respiratory syndrome A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome The Genome Sequence of the SARS-Associated Coronavirus Coronavirus as a possible cause of severe acute respiratory syndrome Severe acute respiratory syndrome Duration of symptom onset to hospital admission and admission to discharge or death in SARS in mainland China: A descriptive study Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: A worldwide study Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group The Middle East Respiratory Syndrome (MERS) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the united states Emergence of Porcine epidemic diarrhea virus in the United States: Clinical signs, lesions, and viral genomic sequences The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China A novel coronavirus outbreak of global health concern Molecular mechanisms of coronavirus RNA capping and methylation Molecular Evolution of Human Coronavirus Genomes The Molecular Biology of Coronaviruses Nidovirales: Evolving the largest RNA virus genome Mechanisms of coronavirus cell entry mediated by the viral spike protein Structure, Function, and Evolution of Coronavirus Spike Proteins Origin and evolution of pathogenic coronaviruses Coronavirus genomics and bioinformatics analysis Pre-fusion structure of a human coronavirus spike protein Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS Biochemical aspects of coronavirus replication and virus-host interaction Coronaviruses post-SARS: update on replication and pathogenesis Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus Discovery and Sequence Analysis of Four Deltacoronaviruses from Birds in the Middle East Reveal Interspecies Jumping with Recombination as a Potential Mechanism for Avian-to-Avian and Avian-to-Mammalian Transmission Cross-Species Transmission of Deltacoronavirus and the Origin of Porcine Deltacoronavirus Bats are natural reservoirs of SARS-like coronaviruses Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis SARS-COV-2 comparison of three emerging coronaviruses Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence Characterization and evaluation of the pathogenicity of a natural recombinant transmissible gastroenteritis virus in China Comparison of mono-and co-infection by swine influenza A viruses and porcine respiratory coronavirus in porcine precision-cut lung slices Porcine epidemic diarrhea virus (PEDV): An update on etiology, transmission, pathogenesis, and prevention and control Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans Entry of scotophilus bat coronavirus-512 and severe acute respiratory syndrome coronavirus in human and multiple animal cells Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats Genetic diversity of coronaviruses in Miniopterus fuliginosus bats Characterization of a new member of alphacoronavirus with unique genomic features in rhinolophus bats Bovine coronavirus in neonatal calf diarrhoea in Iran Porcine hemagglutinating encephalomyelitis virus: A review Experimental inoculation of equine coronavirus into Japanese draft horses Equine Coronavirus-Associated Colitis in Horses: A Retrospective Study Is Associated with a Glycine at Residue 310 of the Spike Glycoprotein Isolation and Characterization of a Novel Betacoronavirus Subgroup A Coronavirus, Rabbit Coronavirus HKU14, from Domestic Rabbits Rapid detection of MERS coronavirus-like viruses in bats: Potential for tracking MERS coronavirus transmission and animal origin Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5 Comparative Analysis of Twelve Genomes of Three Novel Group 2c and Group 2d Coronaviruses Reveals Unique Group and Subgroup Features Coexistence of Different Genotypes in the Same Bat and Serological Characterization of Rousettus Bat Coronavirus HKU9 Belonging to a Novel Betacoronavirus Subgroup Gammacoronavirus and Deltacoronavirus in Quail Molecular and pathogenicity of infectious bronchitis virus (Gammacoronavirus) in Japanese quail (Coturnix japonica) Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray Discovery of a Novel Bottlenose Dolphin Coronavirus Reveals a Distinct Species of Marine Mammal Coronavirus in Gammacoronavirus The emergence of novel sparrow deltacoronaviruses in the United States more closely related to porcine deltacoronaviruses than sparrow deltacoronavirus HKU17 Characterization, pathogenicity and protective efficacy of a cell culture-derived porcine deltacoronavirus The use of cells from ANPEP knockout pigs to evaluate the role of aminopeptidase N (APN) as a receptor for porcine deltacoronavirus (PDCoV) Genetic Recombination, and Pathogenesis of Coronaviruses Severe Acute Respiratory Syndrome Coronavirus Phylogeny: toward Consensus Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Bat origin of human coronaviruses Betacoronavirus genomes: How genomic information has been used to deal with past outbreaks and the covid-19 pandemic The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Recently Discovered Human Coronaviruses New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia Diversity and evolutionary histories of human coronaviruses NL63 and 229E associated with acute upper respiratory tract symptoms in Kuala Lumpur, Malaysia, Am Human coronavirus NL63 associated with lower respiratory tract symptoms in early life Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding Coronavirus HKU1 infection in the United States Human coronaviruses are uncommon in patients with gastrointestinal illness Detection of the new human coronavirus HKU1: A report of 6 cases Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou Human coronavirus infections in Israel: Epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1 Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China Acute Respiratory Distress Syndrome in Critically ill Patients with Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Historical, Epidemiologic, and Clinical Features Al Moummar, Demographic, clinical, and outcomes of confirmed cases of Middle East Respiratory Syndrome coronavirus Kingdom of Saudi Arabia (KSA) A retrospective record based study Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Oral symptoms and lesions in SARS-CoV-2-positive patient SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden Characteristics of Ocular Findings of Patients with Coronavirus Disease Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye Annexin A2 in virus infection Silver nanoparticles as potential antiviral agents A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status The possible mechanisms of action of 4-aminoquinolines (chloroquine/ hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials Effective treatment of severe COVID-19 patients with tocilizumab Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report Tocilizumab treatment in COVID-19: A single center experience Can Zn Be a Critical Element in COVID-19 Treatment? Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects Repositioning of histamine H 1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2 Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study COVID-19: Emergence of Infectious Diseases The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil Chlorophylls and their Derivatives Used in Food Industry and Medicine, Mini COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn 2+ Ions to Inhibit SARS-CoV-2 RNA Synthesis? Therapeutic nanomaterials for cancer therapy and tissue regeneration Carbon nano-onions: A valuable class of carbon nanomaterials in biomedicine Piezoelectric Nano-Biomaterials for Biomedicine and Tissue Regeneration How can nanotechnology help to combat COVID-19? Opportunities and urgent need A Thermostable mRNA Vaccine against COVID-19 Vaccines based on virus-like nanoparticles for use against Middle East Respiratory Syndrome (MERS) coronavirus Systematic Review and Meta-Analysis of the Efficacy of Nanoscale Materials against Coronaviruses-Possible Potential Antiviral Agents for SARS-CoV-2 Nanotechnology for COVID-19: Therapeutics and Vaccine Research Nanotechnology Responses to COVID-19 Nanoparticle-Based Strategies to Combat COVID-19 Nano Research for COVID-19 Covid-19 acute responses and possible long term consequences: What nanotoxicology can teach us No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19 COVID-19 vaccine development and a potential nanomaterial path forward Can nanotechnology help in the fight against COVID-19? Protein degradation and RNA efflux of viruses photocatalyzed by graphene-tungsten oxide composite under visible light irradiation Human coronavirus 229E remains infectious on common touch surface materials Antiviral Nanostructured Surfaces Reduce the Viability of SARS-CoV-2 Bacteria accumulate copper ions and inhibit oxide formation on copper surface during antibacterial efficiency test Copper alloys-The new 'old' weapon in the fight against infectious disease Killing of bacteria by copper surfaces involves dissolved copper Inactivation of influenza A virus on copper versus stainless steel surfaces The COVID-19 Pandemic, Part 1: Can Antimicrobial Copper-Based Alloys Help Suppress Infectious Transmission of Viruses Originating from Human Contact with High-Touch Surfaces? Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Is copper beneficial for COVID-19 patients? Antiviral Activities of Cu 2+ Ions in Viral Prevention, Replication, RNA Degradation, and for Antiviral Efficacies of Lytic Virus, ROS-Mediated Virus Potent antiviral effect of silver nanoparticles on SARS-CoV-2 Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion High-efficiency electrochemical degradation of antiviral drug abacavir using a penetration flux porous Ti/SnO 2 -Sb anode Transformation of molten SnCl 2 to SnO 2 nano-single crystals Solid phase growth of tin oxide nanostructures Thermokinetic characterisation of tin (II) chloride A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection Graphene-based composites Graphene Based Nanomaterials: An Emphasis on Molecular Mechanisms, Surface Engineering and Size of Sheets Enhanced antibacterial and photocatalytic activities of silver nanoparticles anchored reduced graphene oxide nanostructure An outlook into the flat land of 2D materials beyond graphene: Synthesis, properties and device applications, 2D Mater Experimental and theoretical inquiry into optical properties of graphene derivatives Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering Mechanical properties of graphene-reinforced aluminium composite with modified substrate surface: A molecular dynamics study Thermomechanical properties of honeycomb lattices from internal-coordinates potentials: the case of graphene and hexagonal boron nitride, 2D Mater Hybrid graphene metasurfaces for high-speed mid-infrared light modulation and single-pixel imaging Tensile characterization of graphene nanoplatelet/shape memory alloy/epoxy composites using digital and thermal imaging Correlation between morphological, structural and electrical properties of graphite and exfoliated graphene nanostructures Electrochemical interaction between graphite and molten salts to produce nanotubes, nanoparticles, graphene and nanodiamonds Strategies for reduction of graphene oxide -A comprehensive review Graphene oxide and reduced graphene oxide: Efficient cargo platforms for cancer theranostics Green production of carbon nanomaterials in molten salts and applications Green production of carbon nanomaterials in molten salts, mechanisms and applications Synthesis of graphene-like carbon from biomass pyrolysis and its applications Molten salt conversion of polyethylene terephthalate waste into graphene nanostructures with high surface area and ultra-high electrical conductivity Effect of molten salts on the structure, morphology and electrical conductivity of PET-derived carbon nanostructures Graphene and Graphene-Based Materials in Biomedical Science Photothermal-assisted antibacterial application of graphene oxide-Ag nanocomposites against clinically isolated multi-drug resistant Escherichia coli Magnetite nanoparticle decorated reduced graphene oxide for adsorptive removal of crystal violet and antifungal activities Antioxidant, Antibacterial and Anticancer Performance of Reduced Graphene Oxide Prepared via Green Tea Extract Assisted Biosynthesis Graphene-based nanomaterials: the promising active agents for antibiotics-independent antibacterial applications Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis Synergistic antifungal study of PEGylated graphene oxides and copper nanoparticles against Candida albicans Stable and Antibacterial Magnesium-Graphene Nanocomposite-Based Implants for Bone Repair Polymer-based graphene derivatives and microwave-assisted silver nanoparticles decoration as a potential antibacterial agent Carbon-based antiviral nanomaterials: Graphene, C-dots, and fullerenes. A perspective Human virus detection with graphene-based materials Novel graphene-based biosensor for early detection of Zika virus infection A Novel Electrochemical DNA Biosensor Based on a Gold Nanoparticles-Reduced Graphene Oxide Polypyrrole Nanocomposite to Detect Human T-Lymphotropic Virus-1 Ultrasensitive Electrochemical Biosensor for HIV Gene Detection Based on Graphene Stabilized Gold Nanoclusters with Exonuclease Amplification Towards the Electrochemical Diagnostic of Influenza Virus: Development of Graphene-Au Hybrid Nanocomposite Modified Influenza Virus Biosensor Based on Neuraminidase Activity Screen Printed Graphene Oxide Textile Biosensor for Applications in Inexpensive and Wearable Point-of-Exposure Detection of Influenza for At-Risk Populations Ultrasensitive and highly selective electrochemical biosensor for HIV gene detection based on amino-reduced graphene oxide and β-cyclodextrin modified glassy carbon electrode Graphene Quantum Dots for Optical Bioimaging Targeted bioimaging and sensing of folate receptorpositive cancer cells using folic acid-conjugated sulfur-doped graphene quantum dots Novel hybrids based on graphene quantum dots covalently linked to glycol corroles for multiphoton bioimaging Multiplexed Graphene Quantum Dots with Excitation-Wavelength-Independent Photoluminescence, as Two-Photon Probes, and in Ultraviolet-Near Infrared Bioimaging Intrinsic photoluminescence of amine-functionalized graphene derivatives for bioimaging applications Hybrid Graphene-Gold Nanoparticle-Based Nucleic Acid Conjugates for Cancer-Specific Multimodal Imaging and Combined Therapeutics Manganese-nitrogen and gadolinium-nitrogen Co-doped graphene quantum dots as bimodal magnetic resonance and fluorescence imaging nanoprobes Fabrication of Graphene Nanoplatelet-Incorporated Porous Hydroxyapatite Composites: Improved Mechanical and in Vivo Imaging Performances for Emerging Biomedical Applications Graphene-based materials for tissue engineering Fabrication of Graphene Oxide and Nanohydroxyapatite Reinforced Gelatin-Alginate Nanocomposite Scaffold for Bone Tissue Regeneration Coining attributes of ultra-low concentration graphene oxide and spermine: An approach for high strength, antimicrobial and osteoconductive nanohybrid scaffold for bone tissue regeneration Fabrication of graphene/gelatin/chitosan/tricalcium phosphate 3D printed scaffolds for bone tissue regeneration applications Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy Stimuli-responsive grapheneincorporated multifunctional chitosan for drug delivery applications: a review Stimuli responsive drug delivery systems based on nanographene for cancer therapy Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite as antibacterial drug nanocarrier agent Development of multifunctional cobalt ferrite/graphene oxide nanocomposites for magnetic resonance imaging and controlled drug delivery Are graphene and graphene-derived products capable of preventing COVID-19 infection? Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor Self-Reporting and Photothermally Enhanced Rapid Bacterial Killing on a Laser-Induced Graphene Mask Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic Can graphene take part in the fight against COVID-19? Protecting healthcare workers during COVID-19 pandemic with nanotechnology: A protocol for a new device from Egypt Detection of COVID-19: A review of the current literature and future perspectives Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells Electrical pulse-induced electrochemical biosensor for hepatitis E virus detection Covalent functionalization of graphene with reactive intermediates 3D graphene nanoedges as efficient dye adsorbents with ultrahigh thermal regeneration performance Structural Characterization of Graphene Oxide: Surface Functional Groups and Fractionated Oxidative Debris Graphene Oxide/Polymer-Based Biomaterials Virus capture and destruction by labelfree graphene oxide for detection and disinfection applications Thermal reduction of graphene oxide: How temperature influences purity Hydrazine and thermal reduction of graphene oxide: reaction mechanisms, product structures, and reaction design Highly Efficient Multivalent 2D Nanosystems for Inhibition of Orthopoxvirus Particles Size-dependent inhibition of herpesvirus cellular entry by polyvalent nanoarchitectures Herpesvirus Entry: an Update Evidence for an Interaction of Herpes Simplex Virus with Chondroitin Sulfate Proteoglycans during Infection Interaction of silver nanoparticles with HIV-1 Pathogenic differences between various feline coronavirus isolates Infectious bursal disease virus of chickens: Pathogenesis and immunosuppression Detection of infectious bursal disease virus of poultry in clinical samples by RT-PCR T cell subset profile and inflammatory cytokine properties in the gut-associated lymphoid tissues of chickens during infectious bursal disease virus (IBDV) infection Growth and replication of infectious bursal disease virus in the DF-1 cell line and chicken embryo fibroblasts Antiviral activity of graphene-silver nanocomposites against non-enveloped and enveloped viruses Graphene Oxide and Lipid Membranes: Interactions and Nanocomposite Structures Reduced graphene oxide directed selfassembly of phospholipid monolayers in liquid and gel phases Antiviral Activity of Graphene Oxide: How Sharp Edged Structure and Charge Matter Herpes simplex virus type-1 attachment inhibition by functionalized graphene oxide Oxygenated functional group density on graphene oxide: Its effect on cell toxicity Biomechanical features of graphene-augmented inorganic nanofibrous scaffolds and their physical interaction with viruses Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection Innate immune responses in respiratory syncytial virus infections Rapid enrichment and ultrasensitive detection of influenza A virus in human specimen using magnetic quantum dot nanobeads based test strips Sensitive detection of virus with broad dynamic range based on highly bright quantum dot-embedded nanoprobe and magnetic beads Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus High Efficiency of Functional Carbon Nanodots as Entry Inhibitors of Herpes Simplex Virus Type 1 Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies Electronic and phonon bandstructures of pristine few layer and metal doped graphene using first principles calculations Graphene-Based "Hot Plate" for the Capture and Destruction of the Herpes Simplex Virus Type 1 Graphene-Assisted Synthesis of 2D Polyglycerols as Innovative Platforms for Multivalent Virus Interactions Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity Covid-19: Denmark to kill 17 million minks over mutation that could undermine vaccine effort Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): Rapid systematic review and field synopsis Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies Progress in modifications of 3D graphene-based adsorbents for environmental applications Dual-step air-thermal treatment for facile conversion of PET into porous carbon particles with enhanced dye adsorption performance Study of thallium(III) adsorption onto multiwall carbon nanotubes Anti-pathogenic activity of graphene nanomaterials: A review Viral clearance strategies for biopharmaceutical safety Challenges of studying viral aerosol metagenomics andcommunities in comparison with bacterial and fungal aerosols Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin Graphene Quantum Dots Based Systems As HIV Inhibitors Antiviral and Antibacterial Nanostructured Surfaces with Excellent Mechanical Properties for Hospital Applications Inhibitory effect of silver nanomaterials on transmissible virus-induced host cell infections Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus Neutralizing viruses in suspensions by copper oxide-based filters Copper Nanoparticle-Graphene Composite-Based Transparent Surface Coating with Antiviral Activity against Influenza Virus This work was financially supported by the Fundamental Research Funds for the Central Universities (N2025001).